FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 01-Feb 2025. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3111191000001119 | Acalabrutinib maleate | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3111201000001117 | Acalabrutinib maleate (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Acalabrutinib maleate | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some | ||
| Acalabrutinib maleate | Is a | Benzimidazole (substance) | true | Inferred relationship | Some | ||
| Acalabrutinib maleate | Is a | Non-specific protein-tyrosine kinase inhibitor | true | Inferred relationship | Some | ||
| Acalabrutinib maleate | This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. | Non-specific protein-tyrosine kinase inhibitor (disposition) | true | Inferred relationship | Some | ||
| Acalabrutinib maleate | This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. | Acalabrutinib | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets